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Chemokine signaling is a key regulator of stem cell migration and development. However, how chemokine
gradients are generated for signaling purposes is not understood. Sa´nchez-Alcan˜iz et al. and Wang et al.
in this issue of Neuron now describe how the discovery of a new chemokine receptor called CXCR7 helps
to provide answers to this question.Important publications describing the
effects of cytokines in the nervous system
are demanding increasing amounts of our
attention these days. Consider, for
example, the chemotactic cytokines or
chemokines. These small proteins have
been extensively studied because of their
importance in regulating leukocyte migra-
tion and inflammation. Approximately 50
different chemokines have been shown to
exist in higher vertebrates. These can be
organized into four subfamilies based on
structural considerations and, as far as
we know, all their effects are transduced
by a family of G protein coupled receptors
(GPCRs). In most instances, chemokines
are not expressed at high concentrations,
their expression being upregulated in
association with an innate immune or
inflammatory response. However, one
chemokine does not fit this general
description. Stromal cell-derived factor-1
(SDF-1, also called CXCL12) and its
receptor CXCR4 are constitutively ex-
pressed at high levels in many tissues,
including the nervous system (Li and Ran-
sohoff 2008). Evolutionary considerations
have indicated that CXCL12 is the most
ancient chemokine and that it existed in
animals prior to the development of
a sophisticated immune system, suggest-
ing that the original function of chemokine
signaling had nothing to do with immunity
(Huising et al., 2003). The ancient function
of CXCL12/CXCR4 signaling appears to
involve regulating the migration and devel-
opment of the stem cells that generate
nearly every tissue (Miller et al., 2008).
Both CXCL12 and CXCR4 are highly ex-
pressed in the developing embryo, their
distribution changing rapidly over time in
association with the development of
different structures. The overall impor-tance of CXCR4 signaling during develop-
ment has become abundantly clear from
examination of CXCR4 knockout mice,
which exhibit numerous phenotypes
relating to the formation of nearly every
tissue (Li and Ransohoff 2008). CXCR4
signaling regulates the development of
many structures in the brain and peripheral
nervous system, including parts of the
cerebellum, cortex, and hippocampus
and the dorsal root and sympathetic
ganglia. Regulation of stem cell function
by CXCR4 signaling continues in adult
structures such as the bone marrow and
the neurogenic niches of the brain.
Although there is a great deal of data
clearly demonstrating the importance of
CXCR4 signaling in the directed migration
of stem cell populations in the developing
nervous system, details as to how this is
actually accomplished remain to be eluci-
dated. How exactly are gradients of
CXCL12 established and how is the che-
mokine concentration in the local stem
cell microenviroment precisely regulated?
Now two extensive papers published in
this issue of Neuron (Sa´nchez-Alcan˜iz
et al., 2011; Wang et al., 2011) reveal
important details about thesemechanisms
and, specifically, how they help to explain
the manner in which interneurons migrate
into the developing cortex.
The insights provided by these papers
come from consideration of the properties
of a recently described chemokine
receptor known as CXCR7. CXCR7 is
a member of a particular subgroup of che-
mokine receptors, which also include
DARC, D6, and CCXCKR, whose proper-
ties are somewhat unusual for GPCRs
because, even though they bind chemo-
kines, they don’t actually activate
G proteins (Graham 2009). An examinationNeuronof their sequences reveals that these
receptors don’t contain the amino acid
motif that has been typically associated
with the activation ofG proteins by chemo-
kine receptors. So, what do these proteins
do? If they don’t activate G proteins are
they capable of alternative types of
signaling? Nowadays the repertoire of
known signaling pathways associated
with GPCRs is truly immense and so non-
G-protein-related functions can certainly
be envisaged (Rajagopal et al., 2010a).
Moreover, what exactly are their biological
functions? One idea is that these mole-
cules function as ‘‘decoy’’ receptors. That
is to say they can bind chemokines and re-
move them from the external environment
through receptor-mediated endocytosis,
a property commonly associated with
GPCRs. Once internalized by a decoy
receptor, a particular chemokine may be
degraded or even perhaps rereleased
intact from another part of the cell—a
process known as transcytosis. Previ-
ously, receptors like DARC and D6 have
been shown to bind and internalize
numerous chemokines—but not CXCL12.
However, the great interest in CXCR7 is
that it does bind CXCL12 with very high
affinity. In fact, apart from the possibility
that it can also bind CXCL11, CXCL12
appears to be its only ligand. So, does
CXCR7 cooperate with CXCR4 in medi-
ating CXCL12 signaling and, if so, how?
One suggestion is that CXCR7 and
CXCR4 form heterodimers modulating
CXCR4 signaling which normally involves
the activation of Gai/o (Levoye et al.,
2009) Another suggestion is that the two
receptors signal through the activation of
different pathway, which might then
interact intracellularly at some level.
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local environment so that signaling via
theCXCR4 receptor can bemore precisely
defined. Several papers have demon-
strated that CXCR7 can readily interact
with the intracellular scaffold protein
b-arrestin 2, which is associated with
receptor endocytosis (Rajagopal et al.,
2010b). Indeed, it has been observed that
CXCR7 is normally localized intracellularly
and that it rapidly shuttles between the
cell surface and intracellular compart-
ments (Luker et al., 2010).
Over the years the group of investiga-
tors represented by Wang et al. (2011)
have carefully defined the mechanisms
by which the different populations of
cortical GABAergic interneurons develop
from their germinal zones. For example,
progenitor cells localized in the medial
ganglionic eminence (MGE) express
a variety of transcription factors that can
be used to trace their migration and devel-
opment. Deletion of the transcription
factor Lhx6 from the pool of MGE progen-
itors substantially disrupts their normal
path of migration into the cortex. An
important question therefore is what are
the genes downstream of such transcrip-
tion factors that mediate the actual
mechanics of interneuron migration?
Previous publications have demonstrated
that Lhx6 helps to control the expression
of CXCR4 by migrating progenitors and
that CXCR4 and Lhx6 knockout mice
show similar defects in interneuron migra-
tion (Zhao et al., 2008). At the time when
interneuron progenitors migrate from the
MGE, CXCL12 is expressed in two locales
in the developing cortex .The chemokine
is strongly expressed in the meninges
and also in a deeper location that corre-
sponds to the subventricular zone (SVZ)/
intermediate zone (IZ).CXCR4-expressing
progenitors in the MGE form migratory
streams attracted by these sources of
CXCL12 and normally populate the
marginal zone (MZ) and SVZ (Tiveron
et al., 2006). Disruption of CXCR4
signaling causes a failure of migrating
interneurons to populate their normal
destinations and results in overpopulation
of the cortical plate (CP) region from
which they are normally excluded.
Early studies on the phenotypes of
CXCR7 knockout mice did not report any
abnormalities in nervous system develop-
ment. However, the abundant expression2 Neuron 69, January 13, 2011 ª2011 Elsevieof CXCR7 in the developing brain sug-
gested that phenotypes might well be
observed on closer inspection (Scho¨ne-
meier et al., 2008). Indeed, the papers by
Wang et al. (2011) and Sa´nchez-Alcan˜iz
et al. (2011) both demonstrate that not
only is CXCR7 coexpressed with CXCR4
in migrating MGE progenitors but also
that deletion ofCXCR7produces apheno-
type that appears virtually identical to that
observed inCXCR4deficientmice. In both
CXCR4 and CXCR7 mutants, migrating
Lhx6-expressing progenitors exhibit
reduced tangential and increased radial
migration resulting in their enhanced posi-
tioning in the CP at the expense of the MZ
or SVZ. Such observations suggest that
CXCR4/CXCR7 may cooperate in regu-
lating interneuron migration—but how?
Wang et al. (2011) make several important
observations that help in answering this
question. In one experiment, they ectopi-
cally expressed CXCL12 in the cortex of
control or mutant mice. In wild-type mice
Lhx6-expressing progenitors migrated
toward this ectopic source. On the other
hand, no progenitor migration was
observed in either CXCR7 or CXCR4
mutant mice, indicating that expression
of both of these receptors is equally
important for directed migration to occur.
However, when the authors examined
the migratory properties of individual
mutant progenitors in cortical slices, they
found that CXCR4 mutant cells were
more motile and CXCR7 mutant cells
were less motile than wild-type cells.
Hence the authors conclude that the two
receptorsmust have different, but interde-
pendent, signaling consequences in
directing progenitor migration. Further
experiments indicated what these
signaling pathways might be. It is well
known that CXCR4 receptors signal via
the pertussis toxin (PTX)-sensitive
G proteins Gai/o. Using a genetic manipu-
lation for expressing PTX in migrating
interneurons, Wang et al. (2011) demon-
strated that inhibition of Gai/o in these
cells produces the same phenotype as in-
hibiting CXCR4, further illustrating the
importance of CXCR4 signaling. CXCR7
receptors can’t activate Gai/o but are
able to signal via b-arrestin. As b-arrestin
can act as a scaffold protein for intermedi-
ates of the MAP kinase pathway, this
could represent a signaling option for
these receptors. Indeed, Wang et al.r Inc.(2011) do demonstrate that CXCR7 can
activate the MAP kinase pathway in
migrating progenitors.
The mechanism of CXCR4/CXCR7
cooperation is beautifully illuminated by
the studies of Sa´nchez-Alcan˜iz et al.
(2011). These authors also conclude that
migrating interneurons express both
CXCR4 and CXCR7 and that migration is
dependent on both receptors. However,
they make one further absolutely key
observation. They show that migrating
cells that lack CXCR7 in CXCR7 mutant
mice also lack CXCR4 protein expression
(the mRNA is still expressed).Why should
CXCR4 disappear if CXCR7 is removed?
Sa´nchez-Alcan˜iz et al. (2011) show, and
Wang et al. (2011) also observe, that
most of the CXCR7 in migrating interneu-
rons is intracellular, something consistent
with other papers in the literature. Sa´n-
chez-Alcan˜iz et al. (2011) note that
CXCR7 actively recycles between the
membrane and the interior of the cell. It
appears that CXCR7 is constantly
involved in binding and internalizing
CXCL12. Hence, as they predict, Sa´n-
chez-Alcan˜iz et al. (2011) demonstrate
that removal of CXCR7 produces a huge
increase in the extracellular levels of
CXCL12. Normally, when CXCL12 binds
to CXCR4, in addition to G protein activa-
tion, it also produces receptor endocy-
tosis and degradation. Hence, if the
extracellular CXCL12 concentration is
too high, it will trigger endocytosis and
degradation of all of the CXCR4 in the
cell. Viewed in this way, one can see that
the important function for CXCR7 in these
cells is to carefully titrate the concentra-
tion of CXCL12 in the local microenviro-
ment so that just the right amount of
signaling occurs. If CXCR7 disappears,
then extracellular CXCL12 levels will be
too high, overactivation of CXCR4 will
occur and it will also disappear from the
cell. Thus, removal of CXCR7 will result
in the disappearance of CXCR4 and so
this is why both kinds of mutant mice
have the same phenotype—Q.E.D.!
Both papers also demonstrate that
CXCR7 is frequently expressed in the
developing brain in the absence of
CXCR4.The two sets of authors particu-
larly note CXCR7 expression in immature
projection neurons of the CP and in other
areas that are typically avoided by
migrating interneurons. This is also
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a decoy or scavenger receptor helping to
shape gradients of CXCL12 that will deter-
mine paths for CXCR4-mediated chemo-
taxis. Clearly therefore, like all seasoned
performers, CXCR7 is comfortable with
a role either as a soloist or dancing a pas
de deux with CXCR4.
Overall, therefore, these two papers
provide a detailed picture of how two che-
mokine receptors cooperate in enabling
the successful migration of a specific
group of neural progenitors in the devel-
oping brain. And, like all important investi-
gations, they also raise numerous issues
and questions. For example, what is the
significance of CXCR7-induced MAP
kinase activation or other types of cell
signaling ? Is such signaling important in
producing CXCR7-mediated effects in
addition to its scavenging function?
Wang et al. (2011) demonstrate that this
type of signaling occurs, but how it influ-
ences the role of CXCR7 is unclear given
the phenotype produced by PTX activa-
tion in migrating neurons. In addition, the
expression of CXCR7 occurs in cellsoutside the developing embryo, including
in cancer cells, which are often viewed as
cells undergoing a dysregulated form of
development. Given the important role of
CXCR4 signaling in the spread of cancer
metastases (Teicher and Fricker 2010),
the functions of proteins like CXCR7 that
can powerfully modify CXCR4 signaling
are clearly of mechanistic and potentially
therapeutic importance. Indeed, it is now
clear that the discovery of CXCR7 has
added an entirely new dimension to our
understanding of how CXCR4 functions
during development and beyond.
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Activation of NMDA receptors during cerebral ischemia triggers signaling pathways that promote both
neuronal death and survival. In this issue of Neuron, Sasaki et al. present evidence for a new endogenous
survival pathway involving the kinase SIK2 and the CREB coactivator TORC1. The powerful neuroprotection
conferred by this pathway has considerable translational potential for stroke therapy.N-methyl-D-aspartate-type glutamate re-
ceptors (NMDARs) are essential for brain
development and function (Citri and
Malenka, 2007; Cohen and Greenberg,
2008), but they also have adark side, play-
ing central roles in neuronal death during
cerebral ischemia and other brain pathol-
ogies (Szydlowska and Tymianski, 2010).
Remarkably, even in such deleterioussettings, NMDARs set in motion powerful
molecular programs that attempt to pro-
tect neurons from the excitotoxic damage
resulting from their activation. Thus,
NMDARactivation enables the expression
of prosurvival genes through the tran-
scription factor cAMP-response element
binding protein (CREB) (Lonze and Ginty,
2002). Although the involvement of CREBin neuroprotection is well established
(Kitagawa, 2007; Lonze and Ginty, 2002),
the molecular mechanisms by which
NMDAR activation promotes CREB-
dependent neuronal survival, while also
promoting cell death, remain poorly un-
derstood. In this issue of Neuron, Sasaki
et al. (2011) shed light on the issueby iden-
tifying ischemia-induced degradation of69, January 13, 2011 ª2011 Elsevier Inc. 3
